Posted inGeneral Topics, Legal & Regulatory and Reimbursement, Reimbursement Is “Medicare for All” Gaining Political Traction? by William V. Donovan March 5, 2019November 1, 2024
Posted inLegal & Regulatory and Reimbursement FDA to Require Opioid Blister-Packs-Prescribing Guideline in 2020? by William V. Donovan March 4, 2019November 1, 2024
Posted inGeneral Topics, Legal & Regulatory and Reimbursement, Reimbursement Accountable Care Organizations Hit Again – This Time by NEJM by William V. Donovan March 1, 2019November 1, 2024
Posted inGeneral Topics, Legal & Regulatory and Reimbursement, Reimbursement Patients Going to Medicare as Health Costs Rise by William V. Donovan March 1, 2019November 1, 2024
Posted inLegal & Regulatory and Reimbursement Who Is Liveyon and What Are They Really Selling? by William V. Donovan March 1, 2019October 24, 2024
Posted inLegal & Regulatory and Reimbursement Proposed Federal Rule Puts Patient Records on Smart Phones by William V. Donovan February 18, 2019November 1, 2024
Posted inLegal & Regulatory and Reimbursement Opioids: The Action Turns Away from Simply Punishing Physicians by William V. Donovan February 18, 2019October 24, 2024
Posted inLegal & Regulatory and Reimbursement Ambulatory Surgical Center Infections: Awful Headlines in NJ by William V. Donovan February 8, 2019October 24, 2024
Posted inLegal & Regulatory and Reimbursement FDA’s Sort-of-Final 510(k) Proposal by William V. Donovan February 5, 2019October 24, 2024
Posted inLegal & Regulatory and Reimbursement NDA Approvals on a 9-Year Surge; 510(k) Stats – Flat by William V. Donovan February 4, 2019November 1, 2024